FindMyRecallSubscribe
Class I: serious health riskCompleted

Hikma Injectables Phenylephrine in 0 Recall

Phenylephrine in 0

Hikma Injectables USA Inc · Dayton, NJ

Risk level
Class I
Reported by FDA
May 29, 2024
Recall ID
D-0508-2024
Check your lot numberHow we source this data

Summary

Hikma Injectables recalled Phenylephrine in 0 starting Apr 29, 2024. The FDA classified it as Class I (serious health risk) and published enforcement report D-0508-2024 on May 29, 2024. Reason: Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine. Status: Completed.

Why it was recalled

Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.

Product description

Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36 Stults Road, Dayton, NJ 08810, NDC 63037-123-25

Lot numbers, UPCs & expiration codes

Lot #: 240310003D, Exp 6/4/2024

Where it was sold

CO, GA, PA, SD, WA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0508-2024
Classification
Class I
Status
Completed
Recall initiated
Apr 29, 2024
FDA report date
May 29, 2024
Recall type
Voluntary: Firm initiated
Recalling firm
Hikma Injectables USA Inc

Original FDA data

Every field from FDA enforcement report D-0508-2024, exactly as published.

Show all FDA fields
City
Dayton
State
NJ
Status
Completed
Country
United States
Event ID
94522
Address
36 Stults Rd
Code information
Lot #: 240310003D, Exp 6/4/2024
Postal code
08810-1540
Report date
May 29, 2024
Product type
Drugs
Recall number
D-0508-2024
Classification
Class I
Recalling firm
Hikma Injectables USA Inc
Reason for recall
Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36 Stults Road, Dayton, NJ 08810, NDC 63037-123-25
Distribution pattern
CO, GA, PA, SD, WA
Recall initiation date
Apr 29, 2024
Initial firm notification
Letter
Center classification date
May 23, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0508-2024, published May 29, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls